Literature DB >> 14594535

Post-cholecystectomy benign biliary stricture with portal hypertension: is a portosystemic shunt before hepaticojejunostomy necessary?

B Perakath1, V Sitaram, G Mathew, P Khanduri.   

Abstract

BACKGROUND: Portal hypertension develops in 15-20% of patients with benign bile duct stricture. Hepaticojejunostomy in such patients is associated with considerable morbidity and mortality. Preliminary portosystemic shunting has been suggested to reduce intra-operative bleeding. We present our experience without preliminary shunting in such patients. PATIENTS AND METHODS: Fourteen consecutive cases of biliary stricture with portal hypertension over a 13-year period (1989-2001) were retrospectively analysed.
RESULTS: Thirteen patients were operated upon. One patient had a preliminary portosystemic shunt. In another patient, shunt was attempted. One stage hepaticojejunostomy was possible in 11 patients. There were no intra-operative deaths. Nine of the 13 survived and were available for follow-up. One patient had cholangitis. Another had jaundice related both to chronic liver disease and a strictured hepaticojejunostomy. The remaining 7 patients are asymptomatic and anicteric although alkaline phosphatase levels remain elevated in 5 of them.
CONCLUSIONS: Hepaticojejunostomy without preliminary portosystemic shunting is possible in patients with portal hypertension and benign biliary stricture with acceptable morbidity and mortality rates.

Entities:  

Mesh:

Year:  2003        PMID: 14594535      PMCID: PMC1964328          DOI: 10.1308/003588403769162422

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  2 in total

Review 1.  Postcholecystectomy bile duct injury and its sequelae: pathogenesis, classification, and management.

Authors:  Kishore G S Bharathy; Sanjay S Negi
Journal:  Indian J Gastroenterol       Date:  2013-09-03

2.  Management of post-cholecystectomy benign bile duct strictures: review.

Authors:  Sadiq S Sikora
Journal:  Indian J Surg       Date:  2011-12-03       Impact factor: 0.656

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.